Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.


The Blog

Selected category: Cancer

Back to overview

Considering mass spec for therapeutic drug monitoring? Here are 4 pitfalls to avoid

By Dr Manuel Bauer 

As we saw in part 1 of this blog series, liquid chromatography-tandem mass spectrometry (LC-MS/MS) is potentially the new gold standard for therapeutic monitoring of immunosuppressant drugs (ISD). However, for this technology to...

Read more